Tardive dyskinesia--reversible and persistent
- PMID: 35116
- DOI: 10.1001/archpsyc.1979.01780050095012
Tardive dyskinesia--reversible and persistent
Abstract
Twenty-one hospitalized patients over 50 years of age who had tardive dyskinesia were studied for 13 months. After withdrawal of neuroleptics and antidepressants for three months, dyskinetic symptoms abated in 12 patients and persisted in nine. Discriminant function analysis showed that the persistent and reversible dyskinesia groups could be clearly separated and that the best discriminator was the number of drug-free intervals. The persistent dyskinesia group had had significantly longer neuroleptic treatment (mean, 10.8 yr) and a greater number (mean, 5.6) of drug interruptions of at least two months' duration each than did the reversible dyskinesia group. Our finding, as well as the literature reviewed, does not support the commonly held notion that frequent lengthy interruptions of long-term drug treatment reduce the incidence of persistent dyskinesia, at least in patients who are otherwise predisposed to the development of tardive dyskinesia.
Similar articles
-
[Therapeutic measures in tardive dyskinesia].Fortschr Neurol Psychiatr. 1983 Jun;51(6):203-26. doi: 10.1055/s-2007-1002227. Fortschr Neurol Psychiatr. 1983. PMID: 6136457 German.
-
The treatment of tardive dyskinesia.Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8. Schweiz Arch Neurol Psychiatr (1985). 1996. PMID: 8685689 Review.
-
Clinical and epidemiologic aspects of tardive dyskinesia.J Clin Psychiatry. 1985 Apr;46(4 Pt 2):8-13. J Clin Psychiatry. 1985. PMID: 2858483
-
Follow-up study of 11 patients with potentially reversible tardive dyskinesia.Am J Psychiatry. 1987 Nov;144(11):1496-8. doi: 10.1176/ajp.144.11.1496. Am J Psychiatry. 1987. PMID: 2890309
-
Expected incidence of tardive dyskinesia associated with atypical antipsychotics.J Clin Psychiatry. 2000;61 Suppl 4:21-6. J Clin Psychiatry. 2000. PMID: 10739327 Review.
Cited by
-
Tardive dyskinesia.West J Med. 1990 Nov;153(5):535-41. West J Med. 1990. PMID: 1979705 Free PMC article. Review.
-
A depot neuroleptic withdrawal study neurological effects.Psychopharmacology (Berl). 1983;80(2):101-5. doi: 10.1007/BF00427950. Psychopharmacology (Berl). 1983. PMID: 6136059 Clinical Trial.
-
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3. Cochrane Database Syst Rev. 2018. PMID: 29409162 Free PMC article. Review.
-
Cytotoxic effects of neuroleptic drugs.Psychopharmacology (Berl). 1987;91(2):182-8. doi: 10.1007/BF00217059. Psychopharmacology (Berl). 1987. PMID: 2883697
-
Management of Tardive Syndrome: Medications and Surgical Treatments.Neurotherapeutics. 2020 Oct;17(4):1694-1712. doi: 10.1007/s13311-020-00898-3. Neurotherapeutics. 2020. PMID: 32720245 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources